Skip to content

Testing Calcarea Phos 6x for reducing symptoms of muscles and joints in people with vitamin D3 deficiency: A clinical study.

A double-blind randomized placebo control trial utilizing Calcarea Phos 6x in mitigating musculoskeletal manifestations in individuals with vitamin D3 deficiency. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076504
Enrollment
52
Registered
2024-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E559- Vitamin D deficiency, unspecified

Interventions

Intervention1: Calcarea Phosphorica 6x: Homoeopathic medicine Calcarea Phosphorica in the form of biochemic tablets will be given. Dose: 6x. Route of administration : oral . Duration of therapy: 3 mon

Sponsors

Dr Aswani P U
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient attending OPD who falls short of VDIP score will be included for the study. 2.Age group:18 to 45 years. 3.Patients of both sexes. 4.Patients irrespective of their community or socio-economic status. 5.Patient who has given the consent flr the study.

Exclusion criteria

Exclusion criteria: 1. Patient is already under vitamin D supplementation. 2.Pregnant and lactating woman. 3.Patient having chronic illness or are critically ill. 4. Patient having defined life-threatening pathology.

Design outcomes

Primary

MeasureTime frame
To assess the effect of Calcarea Phos 6x in mitigating manifestations related to the musculoskeletal system in individuals with Vitamin D3 deficiency.Timepoint: 3 months with follow-up in each 15 days

Secondary

MeasureTime frame
To study the role of psora in deficiency diseases.Timepoint: 3 months with follow-up in each 15 days.;To assess symptomatic improvement in vitamin D3 deficiency before and after the treatment.Timepoint: 3 months with follow-up in each 15 days along with serum vitamin D3 levels before and after treatment.

Countries

India

Contacts

Public ContactDr Aswani P U

Bharati Vidyapeeth deemed to be university Homoeopathic medical college and hospital

sushma.manhas@bharatividyapeeth.edu9822322533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026